ArticleMolecular cancer2015

Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.

Tobias Bartscht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.